US Stock MarketDetailed Quotes

CTOR Citius Oncology

Watchlist
  • 0.665
  • +0.010+1.53%
Close Mar 28 16:00 ET
  • 0.780
  • +0.115+17.29%
Post 20:01 ET
47.58MMarket Cap-2.06P/E (TTM)

Citius Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--112
--112
--0
--0
-Cash and cash equivalents
--112
--112
--0
--0
Inventory
--14.38M
--8.27M
--0
----
Prepaid assets
--2.7M
-65.09%2.7M
187.52%7.73M
--2.69M
Total current assets
--17.08M
41.81%10.97M
187.52%7.73M
--2.69M
Non current assets
Goodwill and other intangible assets
--73.4M
83.50%73.4M
0.00%40M
--40M
-Other intangible assets
--73.4M
83.50%73.4M
0.00%40M
--40M
Total non current assets
--73.4M
83.50%73.4M
0.00%40M
--40M
Total assets
--90.48M
76.74%84.37M
11.82%47.73M
--42.69M
Liabilities
Current liabilities
Payables
--37.17M
57.30%32.7M
334.36%20.79M
--4.79M
-accounts payable
--5.87M
187.94%3.71M
1,296.42%1.29M
--92.31K
-Due to related parties current
--2.9M
-96.98%588.81K
315.44%19.5M
--4.69M
-Other payable
--28.4M
--28.4M
----
----
Current accrued expenses
--6.23M
--0
-75.58%259.07K
--1.06M
Other current liabilities
----
--1
----
----
Current liabilities
--43.4M
55.37%32.7M
259.98%21.05M
--5.85M
Non current liabilities
Long term debt and capital lease obligation
--3.8M
--3.8M
----
----
-Long term debt
--3.8M
--3.8M
----
----
Non current deferred liabilities
--1.99M
50.00%1.73M
100.00%1.15M
--576K
Other non current liabilities
----
---1
----
----
Total non current liabilities
--5.79M
379.87%5.53M
100.00%1.15M
--576K
Total liabilities
--49.19M
72.21%38.23M
245.63%22.2M
--6.42M
Shareholders'equity
Share capital
--7.16K
6.00%7.16K
0.00%6.75K
--6.75K
-common stock
--7.16K
6.00%7.16K
0.00%6.75K
--6.75K
-Preferred stock
--0
--0
--0
--0
Retained earnings
---45.94M
-116.65%-39.28M
-233.72%-18.13M
---5.43M
Paid-in capital
--87.22M
95.63%85.41M
4.71%43.66M
--41.69M
Total stockholders'equity
--41.29M
80.69%46.14M
-29.59%25.54M
--36.27M
Total equity
--41.29M
80.69%46.14M
-29.59%25.54M
--36.27M
Currency Unit
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --112--112--0--0
-Cash and cash equivalents --112--112--0--0
Inventory --14.38M--8.27M--0----
Prepaid assets --2.7M-65.09%2.7M187.52%7.73M--2.69M
Total current assets --17.08M41.81%10.97M187.52%7.73M--2.69M
Non current assets
Goodwill and other intangible assets --73.4M83.50%73.4M0.00%40M--40M
-Other intangible assets --73.4M83.50%73.4M0.00%40M--40M
Total non current assets --73.4M83.50%73.4M0.00%40M--40M
Total assets --90.48M76.74%84.37M11.82%47.73M--42.69M
Liabilities
Current liabilities
Payables --37.17M57.30%32.7M334.36%20.79M--4.79M
-accounts payable --5.87M187.94%3.71M1,296.42%1.29M--92.31K
-Due to related parties current --2.9M-96.98%588.81K315.44%19.5M--4.69M
-Other payable --28.4M--28.4M--------
Current accrued expenses --6.23M--0-75.58%259.07K--1.06M
Other current liabilities ------1--------
Current liabilities --43.4M55.37%32.7M259.98%21.05M--5.85M
Non current liabilities
Long term debt and capital lease obligation --3.8M--3.8M--------
-Long term debt --3.8M--3.8M--------
Non current deferred liabilities --1.99M50.00%1.73M100.00%1.15M--576K
Other non current liabilities -------1--------
Total non current liabilities --5.79M379.87%5.53M100.00%1.15M--576K
Total liabilities --49.19M72.21%38.23M245.63%22.2M--6.42M
Shareholders'equity
Share capital --7.16K6.00%7.16K0.00%6.75K--6.75K
-common stock --7.16K6.00%7.16K0.00%6.75K--6.75K
-Preferred stock --0--0--0--0
Retained earnings ---45.94M-116.65%-39.28M-233.72%-18.13M---5.43M
Paid-in capital --87.22M95.63%85.41M4.71%43.66M--41.69M
Total stockholders'equity --41.29M80.69%46.14M-29.59%25.54M--36.27M
Total equity --41.29M80.69%46.14M-29.59%25.54M--36.27M
Currency Unit USDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More